HLA-F antibody (AA 71-120)

Catalog No. ABIN6744859

This anti-HLA-F antibody is a Rabbit Polyclonal antibody detecting HLA-F in WB. Suitable for Human and Monkey.

Quick Overview for HLA-F antibody (AA 71-120) (ABIN6744859)

Target: HLA-F (HLAF) (HLA Class I alpha F (HLAF))

Reactivity: Human, Monkey

Host: Rabbit

Clonality: Polyclonal

Conjugate: This HLA-F antibody is un-conjugated

Application: Western Blotting (WB)

Product Details anti-HLA-F Antibody

Binding Specificity: AA 71-120

Specificity: Human HLA-F

Predicted Reactivity: Percent identity by BLAST analysis: Human (100%).

Purification: Immunoaffinity purified

Immunogen: Synthetic peptide located between aa71-120 of human HLA-F (Q5JQI8, NP_001091949). Percent identity by BLAST analysis: Human, Chimpanzee, Monkey (100%).

Type of Immunogen: Synthetic peptide

Application Details

Application Notes: Approved: WB (0.2 - 1 μg/mL)

Usage: Western Blot: Suggested dilution at 1 μg/mL in 5 % skim milk / PBS buffer, and HRP conjugated anti-Rabbit IgG should be diluted in 1: 50,000 - 100,000 as secondary antibody.

Comment:

Target Species of Antibody: Human

Restrictions: For Research Use only

Handling

Format: Lyophilized

Reconstitution: Distilled water

Concentration: Lot specific

Buffer: Lyophilized from PBS with 2 % sucrose

Handling Advice: Avoid repeat freeze-thaw cycles.

Storage: 4 °C,-20 °C

Storage Comment: Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.

Target Details for HLA-F

Target: HLA-F (HLAF) (HLA Class I alpha F (HLAF))

Alternative Name: HLA-F

Background: Name/Gene ID: HLA-F

Synonyms: HLA-F, CDA12, HLAF, HLA-CDA12, MHC class I antigen F, HLA F antigen, MHC class Ib antigen, HLA-5.4, Leukocyte antigen F

Gene ID: 3134

NCBI Accession: NP_001091949

UniProt: P30511

Pathways: Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Human Leukocyte Antigen (HLA) in Adaptive Immune Response